Kintor Pharmaceutical Limited (9939.HK)

HKD 1.31

(9.17%)

Operating Income Summary of Kintor Pharmaceutical Limited

Kintor Pharmaceutical Limited's latest annual operating income in 2023 was -1.06 Billion CNY , down -10.38% from previous year.
Kintor Pharmaceutical Limited's latest quarterly operating income in 2023 FY was -1.06 Billion CNY , down -10.38% from previous quarter.
Kintor Pharmaceutical Limited reported an annual operating income of -969.12 Million CNY in 2022, down -116005.03% from previous year.
Kintor Pharmaceutical Limited reported an annual operating income of -834.69 Thousand CNY in 2021, up 99.79% from previous year.
Kintor Pharmaceutical Limited reported a quarterly operating income of -216.45 Thousand CNY for 2023 Q2, up 50.28% from previous quarter.
Kintor Pharmaceutical Limited reported a quarterly operating income of -1.06 Billion CNY for 2023 FY, down -10.38% from previous quarter.

Annual Operating Income Chart of Kintor Pharmaceutical Limited (2023 - 2014)

Historical Annual Operating Income of Kintor Pharmaceutical Limited (2023 - 2014)

Year	Operating Income	Operating Income Growth
2023	-1.06 Billion CNY	-10.38%
2022	-969.12 Million CNY	-116005.03%
2021	-834.69 Thousand CNY	99.79%
2020	-399.74 Million CNY	-83.18%
2019	-218.21 Million CNY	-198943.18%
2018	-109.63 Thousand CNY	99.76%
2017	-46.08 Million CNY	21.77%
2016	-58.9 Million CNY	-333.27%
2015	-13.59 Million CNY	-40.02%
2014	-9.71 Million CNY	0.0%

Year	Operating Income	Operating Income Growth
2023 Q4	-853.22 Thousand CNY	-294.18%
2023 Q2	-216.45 Thousand CNY	50.28%
2023 FY	-1.06 Billion CNY	-10.38%
2022 FY	-969.12 Million CNY	-116005.03%
2022 Q4	-435.34 Thousand CNY	18.44%
2022 Q2	-533.77 Thousand CNY	-6.35%
2021 FY	-834.69 Thousand CNY	99.79%
2021 Q2	-332.79 Thousand CNY	-47.54%
2021 Q4	-501.9 Thousand CNY	-50.81%
2020 Q4	-225.56 Thousand CNY	-29.5%
2020 FY	-399.74 Million CNY	-83.18%
2020 Q2	-174.18 Thousand CNY	-42.14%
2019 Q4	-122.54 Thousand CNY	-28.08%
2019 Q2	-95.67 Thousand CNY	0.0%
2019 FY	-218.21 Million CNY	-198943.18%
2018 FY	-109.63 Thousand CNY	99.76%
2017 FY	-46.08 Million CNY	21.77%
2017 Q4	-23.53 Thousand CNY	-4.36%
2017 Q2	-22.55 Thousand CNY	-42.7%
2016 Q4	-15.8 Thousand CNY	63.34%
2016 Q2	-43.1 Thousand CNY	0.0%
2016 FY	-58.9 Million CNY	-333.27%
2015 FY	-13.59 Million CNY	-40.02%
2014 FY	-9.71 Million CNY	0.0%

Peer Operating Income Comparison of Kintor Pharmaceutical Limited

Name	Operating Income	Operating Income Difference
Uni-Bio Science Group Limited	67.76 Million HKD	1678.437%
CK Life Sciences Int'l., (Holdings) Inc.	897.95 Million HKD	219.124%